CN106260381A - 一种适合糖尿病人食用的白藜芦醇压片糖果及其制备方法 - Google Patents
一种适合糖尿病人食用的白藜芦醇压片糖果及其制备方法 Download PDFInfo
- Publication number
- CN106260381A CN106260381A CN201610763292.3A CN201610763292A CN106260381A CN 106260381 A CN106260381 A CN 106260381A CN 201610763292 A CN201610763292 A CN 201610763292A CN 106260381 A CN106260381 A CN 106260381A
- Authority
- CN
- China
- Prior art keywords
- resveratrol
- fructus
- pressed candy
- diabetes patient
- food
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 title claims abstract description 36
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 title claims abstract description 36
- 235000021283 resveratrol Nutrition 0.000 title claims abstract description 36
- 229940016667 resveratrol Drugs 0.000 title claims abstract description 36
- 235000009508 confectionery Nutrition 0.000 title claims abstract description 35
- 206010012601 diabetes mellitus Diseases 0.000 title claims abstract description 26
- 238000002360 preparation method Methods 0.000 title claims abstract description 16
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 28
- 235000013305 food Nutrition 0.000 claims abstract description 27
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims abstract description 24
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims abstract description 20
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims abstract description 20
- 239000000811 xylitol Substances 0.000 claims abstract description 20
- 235000010447 xylitol Nutrition 0.000 claims abstract description 20
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims abstract description 20
- 229960002675 xylitol Drugs 0.000 claims abstract description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 16
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 14
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 14
- 239000000463 material Substances 0.000 claims abstract description 14
- 238000003756 stirring Methods 0.000 claims abstract description 14
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 14
- 239000011718 vitamin C Substances 0.000 claims abstract description 14
- 239000005913 Maltodextrin Substances 0.000 claims abstract description 13
- 229920002774 Maltodextrin Polymers 0.000 claims abstract description 13
- 235000013325 dietary fiber Nutrition 0.000 claims abstract description 13
- 229940035034 maltodextrin Drugs 0.000 claims abstract description 13
- 235000019359 magnesium stearate Nutrition 0.000 claims abstract description 12
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims abstract description 12
- 239000008108 microcrystalline cellulose Substances 0.000 claims abstract description 12
- 229940016286 microcrystalline cellulose Drugs 0.000 claims abstract description 12
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims abstract description 11
- 239000002994 raw material Substances 0.000 claims abstract description 11
- 238000000034 method Methods 0.000 claims abstract description 8
- 238000000748 compression moulding Methods 0.000 claims abstract description 4
- 239000000203 mixture Substances 0.000 claims description 22
- 235000009392 Vitis Nutrition 0.000 claims description 10
- 241000219095 Vitis Species 0.000 claims description 10
- 238000002156 mixing Methods 0.000 claims description 8
- 235000003095 Vaccinium corymbosum Nutrition 0.000 claims description 7
- 235000017537 Vaccinium myrtillus Nutrition 0.000 claims description 7
- 235000021014 blueberries Nutrition 0.000 claims description 7
- 240000000851 Vaccinium corymbosum Species 0.000 claims description 6
- 244000269722 Thea sinensis Species 0.000 claims description 3
- 240000001717 Vaccinium macrocarpon Species 0.000 claims description 3
- 235000012545 Vaccinium macrocarpon Nutrition 0.000 claims description 3
- 235000002118 Vaccinium oxycoccus Nutrition 0.000 claims description 3
- 238000001816 cooling Methods 0.000 claims description 3
- 235000004634 cranberry Nutrition 0.000 claims description 3
- 235000021438 curry Nutrition 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 3
- 235000009569 green tea Nutrition 0.000 claims description 3
- 235000008216 herbs Nutrition 0.000 claims description 3
- 238000007689 inspection Methods 0.000 claims description 3
- 230000010354 integration Effects 0.000 claims description 3
- 239000008213 purified water Substances 0.000 claims description 3
- 238000007789 sealing Methods 0.000 claims description 3
- 210000000582 semen Anatomy 0.000 claims description 3
- 239000007921 spray Substances 0.000 claims description 3
- 238000005303 weighing Methods 0.000 claims description 3
- 241000207199 Citrus Species 0.000 claims description 2
- 235000020971 citrus fruits Nutrition 0.000 claims description 2
- 239000000126 substance Substances 0.000 claims description 2
- 235000007516 Chrysanthemum Nutrition 0.000 claims 2
- 244000189548 Chrysanthemum x morifolium Species 0.000 claims 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims 1
- 244000077233 Vaccinium uliginosum Species 0.000 claims 1
- 235000014113 dietary fatty acids Nutrition 0.000 claims 1
- 239000000194 fatty acid Substances 0.000 claims 1
- 229930195729 fatty acid Natural products 0.000 claims 1
- 150000004665 fatty acids Chemical class 0.000 claims 1
- 229910052749 magnesium Inorganic materials 0.000 claims 1
- 239000011777 magnesium Substances 0.000 claims 1
- 238000005070 sampling Methods 0.000 claims 1
- 235000016709 nutrition Nutrition 0.000 abstract description 4
- 230000035764 nutrition Effects 0.000 abstract description 4
- 229930006000 Sucrose Natural products 0.000 abstract description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 abstract description 3
- 235000013402 health food Nutrition 0.000 abstract description 3
- 229960004793 sucrose Drugs 0.000 abstract description 3
- 235000019629 palatability Nutrition 0.000 abstract description 2
- 238000004806 packaging method and process Methods 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 238000010521 absorption reaction Methods 0.000 description 6
- 230000036039 immunity Effects 0.000 description 6
- 230000003064 anti-oxidating effect Effects 0.000 description 4
- 230000002708 enhancing effect Effects 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 3
- 241000628997 Flos Species 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- XFZJEEAOWLFHDH-UHFFFAOYSA-N (2R,2'R,3R,3'R,4R)-3,3',4',5,7-Pentahydroxyflavan(48)-3,3',4',5,7-pentahydroxyflavan Natural products C=12OC(C=3C=C(O)C(O)=CC=3)C(O)CC2=C(O)C=C(O)C=1C(C1=C(O)C=C(O)C=C1O1)C(O)C1C1=CC=C(O)C(O)=C1 XFZJEEAOWLFHDH-UHFFFAOYSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 229920002527 Glycogen Polymers 0.000 description 2
- 206010020710 Hyperphagia Diseases 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- CWEZAWNPTYBADX-UHFFFAOYSA-N Procyanidin Natural products OC1C(OC2C(O)C(Oc3c2c(O)cc(O)c3C4C(O)C(Oc5cc(O)cc(O)c45)c6ccc(O)c(O)c6)c7ccc(O)c(O)c7)c8c(O)cc(O)cc8OC1c9ccc(O)c(O)c9 CWEZAWNPTYBADX-UHFFFAOYSA-N 0.000 description 2
- MOJZMWJRUKIQGL-FWCKPOPSSA-N Procyanidin C2 Natural products O[C@@H]1[C@@H](c2cc(O)c(O)cc2)Oc2c([C@H]3[C@H](O)[C@@H](c4cc(O)c(O)cc4)Oc4c3c(O)cc(O)c4)c(O)cc(O)c2[C@@H]1c1c(O)cc(O)c2c1O[C@@H]([C@H](O)C2)c1cc(O)c(O)cc1 MOJZMWJRUKIQGL-FWCKPOPSSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 230000023852 carbohydrate metabolic process Effects 0.000 description 2
- 235000021256 carbohydrate metabolism Nutrition 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 229940096919 glycogen Drugs 0.000 description 2
- 235000001497 healthy food Nutrition 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 210000004153 islets of langerhan Anatomy 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 238000011275 oncology therapy Methods 0.000 description 2
- 206010036067 polydipsia Diseases 0.000 description 2
- 208000022530 polyphagia Diseases 0.000 description 2
- HGVVOUNEGQIPMS-UHFFFAOYSA-N procyanidin Chemical compound O1C2=CC(O)=CC(O)=C2C(O)C(O)C1(C=1C=C(O)C(O)=CC=1)OC1CC2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 HGVVOUNEGQIPMS-UHFFFAOYSA-N 0.000 description 2
- 229920002414 procyanidin Polymers 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000000087 stabilizing effect Effects 0.000 description 2
- 235000021092 sugar substitutes Nutrition 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 206010008088 Cerebral artery embolism Diseases 0.000 description 1
- 241001672694 Citrus reticulata Species 0.000 description 1
- 206010053567 Coagulopathies Diseases 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 229940123457 Free radical scavenger Drugs 0.000 description 1
- 206010018473 Glycosuria Diseases 0.000 description 1
- 208000032456 Hemorrhagic Shock Diseases 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 101000905241 Mus musculus Heart- and neural crest derivatives-expressed protein 1 Proteins 0.000 description 1
- 241000219780 Pueraria Species 0.000 description 1
- 206010049771 Shock haemorrhagic Diseases 0.000 description 1
- 244000061458 Solanum melongena Species 0.000 description 1
- 235000002597 Solanum melongena Nutrition 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000000702 anti-platelet effect Effects 0.000 description 1
- 230000001147 anti-toxic effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 201000008275 breast carcinoma Diseases 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000001076 estrogenic effect Effects 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- -1 inflammation Chemical class 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 201000010849 intracranial embolism Diseases 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 235000021096 natural sweeteners Nutrition 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 238000005502 peroxidation Methods 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000004223 radioprotective effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- LUKBXSAWLPMMSZ-UHFFFAOYSA-N resveratrol Chemical compound C1=CC(O)=CC=C1C=CC1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-UHFFFAOYSA-N 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/364—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/38—Sucrose-free products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/42—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds characterised by the carbohydrates used, e.g. polysaccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/48—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing plants or parts thereof, e.g. fruits, seeds, extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Health & Medical Sciences (AREA)
- Botany (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Nutrition Science (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
一种适合糖尿病人食用的白藜芦醇压片糖果,其特征在于:以片重500mg计算,按照质量百分比原料包括:木糖醇30‑65%、水溶性膳食纤维10‑30%、天然食品提取物30‑55%、麦芽糊精0.5‑2.5%、维生素C0.5‑2.5%,微晶纤维素0.5‑3.5%、硬脂酸镁0.5‑3.5%,其中白藜芦醇含量10~50mg/片。其制备方法:按所述质量百分比准确称取各原料备用;将天然食品提取物按比例依次加入搅拌;混合物料;将混合均匀的物料,进行压片成型;包装。根据本项发明方法制备的压片糖果酸甜适口,且属于无蔗糖型保健食品,是集绿色、营养、保健于一体的特色食品,不仅适用于普通亚健康人群食用,也适用糖尿病患者食用。
Description
(一)技术领域:
本发明涉及一种白藜芦醇压片糖果及其制备方法,适合糖尿病人食用,属于抗氧化保健食品加工技术领域。
(二)背景技术:
《自然》杂志发表哈佛大学辛克莱教授的研究报告指出:白藜芦醇可能是研发抗衰老药物及抗癌药物的关键。白藜芦醇(Resveratrol)属非黄酮类多酚化合物,是重要的植物抗毒素,抑制癌细胞、降血脂、防治心脑血管疾病、抗氧化、延缓衰老等作用明显,是继紫杉醇之后新型的绿色抗癌药物,也是典型的第三代保健食品原料。
白藜芦醇为天然植物中广泛存在的一种抗逆物质,葡萄中含量很高。白藜芦醇作为一种天然的抗氧化剂,可降低血液粘稠度,抑制血小板凝结和血管舒张,保持血液畅通,可预防癌症的发生及发展,具有抗动脉粥样硬化和冠心病,缺血性心脏病,高血脂的防治作用。抑制肿瘤的作用还具有***样作用,可用于治疗乳腺癌等疾病。20世纪90年代以来,我国科技工作者对白藜芦醇的研究不断深入,并揭示其药理作用:抑制血小板非正常凝聚,预防心肌硬塞、脑栓塞,对缺氧心脏有保护作用,对烧伤或失血性休克引起的心输出量下降有效恢复,并能够扩张动脉血管及改善微循环。1998年美国艾尔·敏德尔编撰《抗衰老圣典》时,将白藜芦醇列为“100种最热门有效抗衰老物质”之一。
配方中的原花青素(OPC)也是有效成份之一,OPC具有强烈的抗氧化作用,其抗氧化能力是维生素C和维生素E的20~50倍,是高效的自由基清除剂。OPC能抑制人体内脂类的过氧化作用,改善微血管的通透性,有利于胶原蛋白的生成,使皮肤有弹性,减少皱纹,延缓人体皮肤衰老,养颜美容。而且,原花青素能阻隔紫外线,增加抗辐射能力,防止过敏、关节炎、白内障、癌症等和自由基有关的疾病,增强免疫力。
木糖醇作为天然甜味剂,其甜度可达到蔗糖的1.2倍,可以将木糖醇作为糖尿病人的甜味剂、营养补充剂和辅助治疗使用。木糖醇是人体糖类代谢的中间体,在体内缺少胰岛素影响糖代谢情况下,无须胰岛素促进,木糖醇吸收利用率高,促进肝糖元合成,提供细胞营养和能量,不引起血糖值升高,消除糖尿病人服用后的三多症状(多食、多饮、多尿),是最适合糖尿病患者食用的营养性的食糖代替品。将木糖醇应用于压片糖果中,不仅能够保持压片糖果的风味,符合SB/T10347-2008压片糖果标准要求,适合糖尿病患者食用,可缓解糖尿病症状,有利于稳定血糖值。
目前市场上抗氧化和增强机体免疫力的各类食品很多,以天然植物中的白藜芦醇为原料制成的食品也不少。但是,市场上尚缺乏高效抗氧化、抗紫外辐射和增强免疫力的食品,由于现有的白藜芦醇产品、饮品、粉剂等均存在食用、存储和携带不方便、人体吸收利用度不高的、口感不好、升高血糖等问题。因此,克服现有产品存在的弊端,开发一种高效抗氧化、增强免疫力的、携带方便的、食用方便的、人体吸收利用高、口感好、广泛适合糖尿病人食用的产品。
(三)发明内容:
本发明的目的在于提供一种适合糖尿病人食用的白藜芦醇压片糖果及其制备方法,它能够解决现有技术的不足,是一种高效抗氧化、提高免疫力的白藜芦醇压片糖果食品,和一种储存方便、食用方便的、携带方便的、人体吸收利用度高、口感好、广泛适合糖尿病人食用的压片糖果制备方法。
为实现上述目的,本发明提供如下技术方案:
一种适合糖尿病人食用的白藜芦醇压片糖果,其特征在于:以片重500mg计算,按照质量百分比原料包括:木糖醇30-65%、水溶性膳食纤维10-30%、天然食品提取物30-55%、麦芽糊精0.5-2.5%、维生素C0.5-2.5%,微晶纤维素0.5-3.5%、硬脂酸镁0.5-3.5%,其中白藜芦醇含量10~50mg/片。
所述天然食品提取物为国家新颁布的药食同源和新资源食品,包括但不限于以下至少三种混合:苹果、蓝莓、葡萄、柑橘、蔓越莓、绿茶、山楂、枸杞、花生、葛根、生姜、桑椹、番茄、红枣、菊花、乌梅、咖喱、山药、猕猴桃等。
作为优选,本发明的原料组成及各成分的质量百分比为:以片重500mg计算,木糖醇45%、水溶性膳食纤维10%、天然食品提取物40%(葡萄、苹果、葛根、山药按质量比5:3:2:1比例搅拌混匀)、麦芽糊精1.7%、维生素C1.8%,微晶纤维素0.5%、硬脂酸镁1%,其中白藜芦醇含量20mg/片。
本发明还提供了一种适合糖尿病人食用的白藜芦醇压片糖果的制备方法,其特征在于它包括以下步骤:
(1)按所述质量百分比准确称取各原料,原料分别粉碎,过80目筛备用;
(2)将天然食品提取物按比例依次加入搅拌,待全部加入后继续搅拌10-15min,混匀备用;
(3)将(2)预混预热15分钟,使得物料温度达到40度以上,开始喷纯化水,进行制粒,烘干,烘干室物料物料温度控制在60度,水分控制在5%以下,进行自然冷却,得到混合物1;
(4)将木糖醇、水溶性膳食纤维、维生素C、麦芽糊精均匀混合,得到混合物2;
(5)将硬脂酸镁、微晶纤维素均匀混合,得到混合物3;
(6)将混合物1、混合物2和混合物3按照等量递增的方法进行总混45分钟,并通过取样化验是否均匀,若均匀,则进行下一步骤操作;
(7)将混合均匀的物料,进行压片成型;
(8)对压片进行包衣,制备结束后,按照SB/T10347-2008压片糖果标准进行取样检验,检验合格,进行包装;
(9)分装,设定封口温度为148℃~149℃,使制成的袋边缘对齐、平整、压痕均匀,不漏气。然后贴标签、检验、外包装、入库。
与现有技术相比,本发明涉及的白藜芦醇压片糖果及其制备方法具有以下优点:
(1)本发明所用天然食品提取物为国家新颁布的药食同源和新资源食品:蓝莓、柑橘、蔓越莓、绿茶、葡萄、苹果、山楂、枸杞、花生、葛根、生姜、桑椹、番茄、红枣、菊花、乌梅、咖喱、山药、猕猴桃等。通过科学配伍,充分发挥各原料间的互补协调作用,服用能抗氧化抗疲劳抗辐射,提高免疫力,降低“三高”。
(2)本发明将制成的白藜芦醇压片糖果为市场提供一种储存方便、食用方便的、携带方便的、人体吸收利用度高、口感好、广泛适合糖尿病人食用的新型保健食品,在压片糖果制作过程中,温度未超过60度,对其中有效成分没有造成破坏。
(3)本项发明所述的原料中以木糖醇是人体糖类代谢的中间体,在体内缺少胰岛素影响糖代谢情况下,无须胰岛素促进,木糖醇吸收利用率高,促进肝糖元合成,提供细胞营养和能量,不引起血糖值升高,消除糖尿病人服用后的三多症状(多食、多饮、多尿),是最适合糖尿病患者食用的营养性的食糖代替品。将木糖醇应用于压片糖果中,不仅能够保持压片糖果的风味,符合SB/T10347-2008压片糖果标准要求,适合糖尿病患者食用,可以缓解糖尿病症状,有利于稳定血糖值。
根据本项发明方法制备的压片糖果酸甜适口,且属于无蔗糖型保健食品,是集绿色、营养、保健于一体的特色食品,不仅适用于普通亚健康人群食用,也适用糖尿病患者食用。
(四)具体实施方式:
实施例1:
以片重500mg计算,木糖醇45%、水溶性膳食纤维10%、天然食品提取物40%(葡萄、苹果、葛根、山药按5:3:2:1比例搅拌混匀)、麦芽糊精1.7%、维生素C1.8%,微晶纤维素0.5%、硬脂酸镁1%,其中白藜芦醇含量20mg/片。
具体步骤如下:
(1)按所述质量百分比准确称取各原料,原料分别粉碎,过80目筛备用;
(2)将天然食品提取物按比例依次加入搅拌,待全部加入后继续搅拌10-15min,混匀备用;
(3)将(2)预混预热15分钟,使得物料温度达到40度以上,开始喷纯化水,进行制粒,烘干,烘干室物料物料温度控制在60~70度之间,水分控制在5%以下,进行自然冷却,得到混合物1;
(4)将木糖醇、水溶性膳食纤维、维生素C、麦芽糊精均匀混合,得到混合物2;
(5)将硬脂酸镁、微晶纤维素均匀混合,得到混合物3;
(6)将混合物1、混合物2和混合物3按照等量递增的方法进行总混45分钟,并通过取样化验是否均匀,若均匀,则进行下一步骤操作;
(7)将混合均匀的物料,进行压片成型;
(8)对压片进行包衣,制备结束后,按照SB/T10347-2008压片糖果标准进行取样检验,检验合格,进行包装。
(9)分装,设定封口温度为148℃~149℃,使制成的袋边缘对齐、平整、压痕均匀,不漏气。然后贴标签、检验、外包装、入库。
实施例2:
以片重500mg计算,木糖醇40%、水溶性膳食纤维5%、天然食品提取物50%(枸杞、葡萄、蓝莓、菊花、山药按2:4:2:1:1比例搅拌混匀)、麦芽糊精0.8%、维生素C1.2%,微晶纤维素1.5%、硬脂酸镁1.5%,其中白藜芦醇含量25mg/片。
制备方法同实施例1。
实施例3:
以片重500mg计算,木糖醇30%、水溶性膳食纤维15%、天然食品提取物50%(葛根、枸杞、葡萄、蓝莓、山药按2:1:4:2:1比例搅拌混匀)、麦芽糊精1.3%、维生素C0.7%,微晶纤维素1.2%、硬脂酸镁1.8%,其中白藜芦醇含量30mg/片。
制备方法同实施1。
产品质量标准
按照SB/T10347-2008,GB 5009.3-2003,GB/T 5009.8-2003,GB/T 5009.11-2003,GB/T 4789.24-2003方法测定产品中各项指标。
Claims (8)
1.一种适合糖尿病人食用的白藜芦醇压片糖果,其特征在于:以片重500mg计算,按照质量百分比原料包括:木糖醇30-65%、水溶性膳食纤维10-30%、天然食品提取物30-55%、麦芽糊精0.5-2.5%、维生素C0.5-2.5%,微晶纤维素0.5-3.5%、硬脂酸镁0.5-3.5%,其中白藜芦醇含量10~50mg/片。
2.根据权利要求1所述一种适合糖尿病人食用的白藜芦醇压片糖果,其特征在于:所述天然食品提取物为国家新颁布的药食同源和新资源食品,包括但不限于以下至少三种混合:苹果、蓝莓、葡萄、柑橘、蔓越莓、绿茶、山楂、枸杞、花生、葛根、生姜、桑椹、番茄、红枣、菊花、乌梅、咖喱、山药、猕猴桃。
3.根据权利要求1所述一种适合糖尿病人食用的白藜芦醇压片糖果,其特征在于:以片重500mg计算,木糖醇45%、水溶性膳食纤维10%、天然食品提取物40%(葡萄、苹果、葛根、山药按质量比5:3:2:1比例搅拌混匀)、麦芽糊精1.7%、维生素C1.8%,微晶纤维素0.5%、硬脂酸镁1%,其中白藜芦醇含量20mg/片。
4.根据权利要求1所述一种适合糖尿病人食用的白藜芦醇压片糖果,其特征在于:以片重500mg计算,木糖醇40%、水溶性膳食纤维5%、天然食品提取物50%(枸杞、葡萄、蓝莓、菊花、山药按2:4:2:1:1比例搅拌混匀)、麦芽糊精0.8%、维生素C1.2%,微晶纤维素1.5%、硬脂酸镁1.5%,其中白藜芦醇含量25mg/片。
5.根据权利要求1所述一种适合糖尿病人食用的白藜芦醇压片糖果,其特征在于:以片重500mg计算,木糖醇30%、水溶性膳食纤维15%、天然食品提取物50%(葛根、枸杞、葡萄、蓝莓、山药按2:1:4:2:1比例搅拌混匀)、麦芽糊精1.3%、维生素C0.7%,微晶纤维素1.2%、硬脂酸镁1.8%,其中白藜芦醇含量30mg/片。
6.一种适合糖尿病人食用的白藜芦醇压片糖果的制备方法,其特征在于它包括以下步骤:
(1)按所述质量百分比准确称取各原料,原料分别粉碎,过80目筛备用;
(2)将天然食品提取物按比例依次加入搅拌,待全部加入后继续搅拌10-15min,混匀备用;
(3)将(2)预混预热15分钟,使得物料温度达到40度以上,开始喷纯化水,进行制粒,烘干,烘干室物料物料温度控制在60度,水分控制在5%以下,进行自然冷却,得到混合物1;
(4)将木糖醇、水溶性膳食纤维、维生素C、麦芽糊精均匀混合,得到混合物2;
(5)将硬脂酸镁、微晶纤维素均匀混合,得到混合物3;
(6)将混合物1、混合物2和混合物3按照等量递增的方法进行总混45分钟,并通过取样化验是否均匀,若均匀,则进行下一步骤操作;
(7)将混合均匀的物料,进行压片成型。
7.根据权利要求6所述一种适合糖尿病人食用的白藜芦醇压片糖果的制备方法,其特征在于对步骤(7)制成的压片进行包衣,制成压片糖果;制备结束后,按照SB/T10347-2008压片糖果标准进行取样检验,检验合格,进行包装。
8.根据权利要求7所述一种适合糖尿病人食用的白藜芦醇压片糖果的制备方法,其特征在于对制成的压片糖果进行分装,设定封口温度为148℃~149℃,使制成的袋边缘对齐、平整、压痕均匀,不漏气;然后贴标签、检验、外包装、入库。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610763292.3A CN106260381A (zh) | 2016-08-29 | 2016-08-29 | 一种适合糖尿病人食用的白藜芦醇压片糖果及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610763292.3A CN106260381A (zh) | 2016-08-29 | 2016-08-29 | 一种适合糖尿病人食用的白藜芦醇压片糖果及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106260381A true CN106260381A (zh) | 2017-01-04 |
Family
ID=57675544
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610763292.3A Pending CN106260381A (zh) | 2016-08-29 | 2016-08-29 | 一种适合糖尿病人食用的白藜芦醇压片糖果及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106260381A (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107535670A (zh) * | 2017-10-31 | 2018-01-05 | 厦门市诚安毅科技有限公司 | 一种食药两用的维生素复合型糖果及其制备方法 |
CN108902433A (zh) * | 2018-07-26 | 2018-11-30 | 兴义市黔农居养种植农民专业合作社 | 一种红糖粉及制备方法 |
CN109315574A (zh) * | 2018-10-12 | 2019-02-12 | 肖文中 | 一种桑叶苦瓜压片糖果 |
Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101264177A (zh) * | 2008-04-30 | 2008-09-17 | 津市市中意糖果有限公司 | 一种具有提神清咽利喉作用的压片糖果 |
CN101606566A (zh) * | 2008-06-18 | 2009-12-23 | 刁媛媛 | 一种功能性口嚼及口崩压片糖果的制备方法及应用 |
CN103734446A (zh) * | 2014-01-22 | 2014-04-23 | 丁圣权 | 一种含玛卡的压片糖果及其制作方法 |
CN104473084A (zh) * | 2014-12-29 | 2015-04-01 | 贵阳学院 | 蓝莓皮、渣多维营养咀嚼片 |
CN104489692A (zh) * | 2015-01-22 | 2015-04-08 | 北京世纪合辉医药科技股份有限公司 | 一种含天然来源白藜芦醇的保健食品及其制备方法 |
CN104621574A (zh) * | 2015-02-04 | 2015-05-20 | 南阳市新天地生物科技有限公司 | 适用于糖尿病患者食用的配方食品及其制备方法 |
CN105053490A (zh) * | 2015-09-21 | 2015-11-18 | 大连丹特生物技术有限公司 | 一种辣木籽压片糖及其制备方法 |
CN105360558A (zh) * | 2015-12-07 | 2016-03-02 | 新疆罗克曼爱科生物科技有限公司 | 一种排毒减肥降脂糖及其生产工艺 |
CN105494844A (zh) * | 2014-10-20 | 2016-04-20 | 威海新异生物科技有限公司 | 一种枸杞压片糖果生产方法 |
CN105580953A (zh) * | 2014-10-20 | 2016-05-18 | 威海新异生物科技有限公司 | 一种桑枣压片糖果生产方法 |
CN105661504A (zh) * | 2016-01-14 | 2016-06-15 | 新疆科宇科技有限公司 | 一种富含白藜芦醇的葡萄皮、籽提取物含片的生产方法 |
-
2016
- 2016-08-29 CN CN201610763292.3A patent/CN106260381A/zh active Pending
Patent Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101264177A (zh) * | 2008-04-30 | 2008-09-17 | 津市市中意糖果有限公司 | 一种具有提神清咽利喉作用的压片糖果 |
CN101606566A (zh) * | 2008-06-18 | 2009-12-23 | 刁媛媛 | 一种功能性口嚼及口崩压片糖果的制备方法及应用 |
CN103734446A (zh) * | 2014-01-22 | 2014-04-23 | 丁圣权 | 一种含玛卡的压片糖果及其制作方法 |
CN105494844A (zh) * | 2014-10-20 | 2016-04-20 | 威海新异生物科技有限公司 | 一种枸杞压片糖果生产方法 |
CN105580953A (zh) * | 2014-10-20 | 2016-05-18 | 威海新异生物科技有限公司 | 一种桑枣压片糖果生产方法 |
CN104473084A (zh) * | 2014-12-29 | 2015-04-01 | 贵阳学院 | 蓝莓皮、渣多维营养咀嚼片 |
CN104489692A (zh) * | 2015-01-22 | 2015-04-08 | 北京世纪合辉医药科技股份有限公司 | 一种含天然来源白藜芦醇的保健食品及其制备方法 |
CN104621574A (zh) * | 2015-02-04 | 2015-05-20 | 南阳市新天地生物科技有限公司 | 适用于糖尿病患者食用的配方食品及其制备方法 |
CN105053490A (zh) * | 2015-09-21 | 2015-11-18 | 大连丹特生物技术有限公司 | 一种辣木籽压片糖及其制备方法 |
CN105360558A (zh) * | 2015-12-07 | 2016-03-02 | 新疆罗克曼爱科生物科技有限公司 | 一种排毒减肥降脂糖及其生产工艺 |
CN105661504A (zh) * | 2016-01-14 | 2016-06-15 | 新疆科宇科技有限公司 | 一种富含白藜芦醇的葡萄皮、籽提取物含片的生产方法 |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107535670A (zh) * | 2017-10-31 | 2018-01-05 | 厦门市诚安毅科技有限公司 | 一种食药两用的维生素复合型糖果及其制备方法 |
CN108902433A (zh) * | 2018-07-26 | 2018-11-30 | 兴义市黔农居养种植农民专业合作社 | 一种红糖粉及制备方法 |
CN109315574A (zh) * | 2018-10-12 | 2019-02-12 | 肖文中 | 一种桑叶苦瓜压片糖果 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106562438A (zh) | 一种增强免疫力的组合物及其制备方法 | |
CN103749872B (zh) | 一种高附加值苦荞产品及其制备方法 | |
CN102106539B (zh) | 降血脂保健食品 | |
CN102934710A (zh) | 一种苦荞茶及其制备工艺 | |
CN103125942A (zh) | 人参苦荞麦功能食品及其制备方法 | |
CN101129442A (zh) | 红景天沙棘片及其制备方法 | |
CN110447902A (zh) | 一种具有减肥功效的组合物 | |
CN110051815A (zh) | 一种辅助降血糖食丸及其制备方法 | |
CN110604303A (zh) | 一种黄精膏及其制备方法 | |
CN106260381A (zh) | 一种适合糖尿病人食用的白藜芦醇压片糖果及其制备方法 | |
CN106479803A (zh) | 一种药酒曲 | |
CN103493940B (zh) | 一种雪菊苦荞组合物及其制备方法 | |
CN106417817A (zh) | 一种袋泡助眠安神茶及其制备方法 | |
CN107343935A (zh) | 一种用于小儿健脾的粉剂及其制备方法 | |
CN103734420B (zh) | 一种刺梨石竹茶及其制作方法 | |
CN103860880A (zh) | 一种枇杷膏及其制备方法 | |
CN102940182A (zh) | 一种低能量蜂胶硬胶囊的制备方法 | |
CN107320569A (zh) | 一种平脂咀嚼片及其制备方法 | |
CN104137999B (zh) | 一种瘦身减肥的食疗组合物和辅料制得的保健品及其制备方法 | |
CN102614404B (zh) | 一种具有辅助降血糖功能的保健品及其制备方法 | |
CN101991773B (zh) | 一种枇杷肉提炼成枇杷膏及其制备方法 | |
CN101317929A (zh) | 一种通阳化气利水胶囊的制作方法 | |
CN109122985A (zh) | 一种黄精降血糖养生茶及其制备方法 | |
CN101317924A (zh) | 一种温补脾肾胶囊的制作方法 | |
CN110585321A (zh) | 一种用于防治贫血的中药组合物及其制备方法与应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170104 |